Sixty-three patients with paralysis secondary to spinal cord injury (SCI) were screened for
heterotopic ossification (HO) by bone scintigraphy 27±14 (mean±SD) days after SCI. There …

A new protocol in management of heterotopic ossification (HO) was evaluated in 46 patients
after spinal cord injury (SCI). A group of 24 paraplegic and 22 tetraplegie patients was …

Forty patients with spinal cord injury (SCI) and heterotopic ossification (HO) were treated
with etidronate and followed after therapy to determine the effects of long-term medication …

The goal of the present study was to use intravenous etidronate in the acute phase of
heterotopic ossification (HO) in an attempt to achieve a high initial drug concentration at the …

Objectives: To determine the effect of indomethacin on the prevention of heterotopic
ossification (HO) following spinal cord injury (SCI). Setting: County Hospital, Miami, Florida …

We evaluated the progression of heterotopic ossification (HO) in 17 spinal cord injury
patients by comparing radiographs, quantitative radionuclide bone scans, and serum …

Heterotopic ossification (HO) is a frequent complication in patients with a spinal cord injury
(SCI), although the aetiology is unknown. A study was undertaken of 654 SCI patients with …

From 1981 to 1986 we treated 413 patients for acute spinal-cord injuries. We reviewed 356
patients followed for a minimum of two years of whom 71 (20%) developed heterotopic …

Heterotopic ossification (HO) is an important complication of spinal cord and brain injuries
but is rarely reported among patients with non-traumatic myelopathies. In a prospective …

Heterotopic ossification is the formation of new bone in an abnormal location. It is usually
seen following central nervous system disorders, including spinal cord injury, traumatic brain …